Francis E. O'Donnell, Jr., M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Francis E. O'Donnell, Jr., M.D.
Francis E. O'Donnell, Jr., M.D. is recorded as Chairman and CEO at Inhibitor Therapeutics, Inc. (INTI). Inhibitor Therapeutics, Inc. reported in an 8-K filed December 19, 2022 that Francis E. O'Donnell, Jr., M.D. was appointed Chief Executive Officer of the Company, effective December 13, 2022. Inhibitor Therapeutics, Inc. reported in an 8-K filed December 19, 2022 that Francis E. O'Donnell, Jr., M.D. was appointed Executive Chairman of its Board, effective December 13, 2022.
“On December 13, 2022, the Board of the Company appointed Francis E. O'Donnell, Jr., M.D. as Executive Chairman of its Board and as Chief Executive Officer of the Company.”
“On December 13, 2022, the Board of the Company appointed Francis E. O'Donnell, Jr., M.D. as Executive Chairman of its Board and as Chief Executive Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-12-13–present
-
Current
2022-12-13–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Inhibitor Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Francis E. O'Donnell CEO, Board Member
- Francis E. O'Donnell, Jr. CEO, Chairman
- James A. McNulty CFO
- James A. McNulty, CPA CFO
- Michael Jerman Board Member
- Michael Jerman, CPA. Board Member
- Michelle Yanez Board Member
- Michelle Yanez, MBA Board Member
- Niraj Vasisht Board Member
- Niraj Vasisht, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.